Sales of cough and sore throat drops decrease precipitously in the summer months, when the cold-season sniffles turn to hurricane-season sweats. In the 13 weeks that ended on June 13, sales in the US for cough drops totalled $245 million, compared to $351.1 million for the blizzardy 13-week period that ended March 29, according to Circana data provided to Retail Brew. That’s a drop (a drop drop!) of 30.2%. Similarly, sales in the category plummeted 38.7% in the second quarter of 2025 compared to the first quarter, per Circana. Now Ricola, the 96-year-old Swiss herb drops brand, has a strategy to increase sales in the warmer months that, in every sense, is nothing to sneeze at. It’s introducing three flavors of lozenges that are not for colds or coughs but rather for everyday use. Instead of addressing coughs or sore throats, packaging describes them as “refreshingly mouthwatering.” “The throat care category right now is really about when that consumer is sick, and we know and see that consumers want to utilize the category for when they’re not sick,” Becky Spruck, senior director of marketing at Ricola USA, told Retail Brew. But as much as boosting warm-weather sales, the new products are also meant to appeal to the lifestyles and taste buds of younger consumers, who Spruck said increasingly turn to home remedies such as gargling with salt water over throat drops. The flavors had “high appeal” when tested with Gen Z and millennials, who Ricola aspires to draw into the category with the new products. The goal is “high consumer acquisition—that’s our lead strategy here,” Spruck said. Keep reading here.—AAN |